https://www.selleckchem.com/pr....oducts/Temsirolimus.
Future interventions should consider these factors in order to reduce percentage of brand-name drugs filled and decrease health care expenditures.BACKGROUND Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in men and women. The presence of systemic disease, with metastatic spread to distant sites such as the liver, considerably reduces the survival rate in CRC. Cancer stem cells contribute to the metastatic potential of CRC. However, the mechanism underlying metastasis in CRC remains unclear. Thus, this